Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical Trial Katie Lew · August 29, 2024
August 29, 2024 Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical TrialGround-breaking investigational product from Melodi Health is designed to reduce post-surgical infections
August 27, 2024 NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease TreatmentEXCELSIOR, Minn. – Aug. 27, 2024 – PRLog — NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced
August 27, 2024 Biocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter CoatingHorsham, PA, [August 27, 2024] – Biocoat Incorporated, a leader in the
EventsWomen in Health Leadership Featuring Dr. Charisse Sparks – Event Recap Katie LewApril 11, 2024 Women in Health Leadership Featuring Dr. Charisse Sparks – Event Recap
NewsChildren’s Minnesota Expands Specialty Care Services in Minnetonka Tyler MasonApril 10, 2024 Children’s Minnesota Expands Specialty Care Services in Minnetonka
News Atmo Biosciences Reaches Primary Endpoints in Pivotal Clinical Study for Initial Indication Tyler MasonApril 9, 2024 Atmo Biosciences Reaches Primary Endpoints in Pivotal Clinical Study for Initial Indication
NewsIn the Know: Healthcare News for April 8, 2024 Tyler MasonApril 5, 2024 In the Know: Healthcare News for April 8, 2024